Ocular Therapeutix (OCUL) Tops Q3 EPS by 4c

Ocular Therapeutix (NASDAQ: OCUL) reported Q3 EPS of ($0.25), $0.04 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $15.08 million versus the consensus estimate of $15.23 million.

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Kepler Cheuvreux Starts Jet2 plc (JET2:LN) (DRTGF) at Buy
• Advance Auto Parts falls on revenue miss, weak guidance